# CISPLATIN
> **ANDA207323** · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2017-03-17
## Drug
- **FDA Application Number:** ANDA207323
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CISPLATIN
- **Generic name:** CISPLATIN
- **Active ingredients:** CISPLATIN
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** GLAND
- **Manufacturer:** Sagent Pharmaceuticals
- **First approval:** 2017-03-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207323)
---
*AI Analytics · CC0 1.0*